Is MedMen Enterprises Stock a Buy?
Like the vast majority of pot stocks, MedMen Enterprises (OTC: MMNFF) has been taken to the proverbial cleaners, so to speak. The company has lost almost four-fifths of its market value since the beginning of the year and has become one of the worst-performing pot stocks in the entire industry. While other cannabis stocks have seen similar declines and have now become potential value investments, there's still a lot to question about MedMen Enterprises before anyone should even consider buying its shares.
Whether that be the company's ongoing financial losses, its recently suspended PharmaCann acquisition, or high executive turnover, Wall Street has more than enough reasons to be bearish on MedMen. Let's go through a few of these reasons and decide for ourselves whether this pessimism is justified.
IMAGE SOURCE: GETTY IMAGES.
Source Fool.com